Literature DB >> 21124037

Association between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.

Konstantinos P Economopoulos1, Theodoros N Sergentanis, Flora Zagouri, George C Zografos.   

Abstract

BACKGROUND: This meta-analysis on case-control studies aims to examine whether the p53 Arg72Pro polymorphism is associated with colorectal cancer risk, addressing also whether the effect of the polymorphism is modified by race. PATIENTS AND METHODS: Pooled odds ratios (ORs) were appropriately derived from fixed-effects or random-effects models. Separate analyses were conducted on Caucasian, Chinese, and mixed populations. Meta-regression with publication year was also performed.
RESULTS: A total of 27 studies were eligible (7,414 cases and 9,872 controls); 19 of them were conducted on Caucasian populations (6282 cases and 7600 controls), 6 of them on Chinese populations (883 cases and 1,843 controls) and 2 on mixed populations (153 cases and 209 controls). No significant association was demonstrated in Caucasian, Chinese, or mixed populations. Interestingly, however, stratification by race in studies whose controls did not deviate from the Hardy-Weinberg equilibrium tended to reveal ORs pointing to a marginal protective effect of the Pro allele in Caucasians.
CONCLUSIONS: The p53 codon 72 Arg72Pro status does not seem to be associated with colorectal cancer risk, although race-specific effects may not be ruled out. However, additional studies seem desirable, especially in Chinese populations.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21124037     DOI: 10.1159/000322210

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  7 in total

1.  Polymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: Association with colorectal cancer susceptibility risk in a Malaysian population.

Authors:  Mohd Nizam Zahary; Abdul Aziz Ahmad Aizat; Gurjeet Kaur; Lee Yeong Yeh; Maya Mazuwin; Ravindran Ankathil
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

2.  TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.

Authors:  Rym Abderrahmane; Lotfi Louhibi; Fatima Zohra Moghtit; Amina Boubekeur; Khedidja Benseddik; Abdellah Boudjema; Fouzia Benrrahal; Meriem Aberkane; Mostefa Fodil; Nadhira Saidi-Mehtar
Journal:  Pathol Oncol Res       Date:  2014-12-24       Impact factor: 3.201

3.  Multiple pathway-based genetic variations associated with tobacco related multiple primary neoplasms.

Authors:  Ashwin Kotnis; Junghyun Namkung; Sadhana Kannan; Nallala Jayakrupakar; Taesung Park; Rajiv Sarin; Rita Mulherkar
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

4.  Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method.

Authors:  B Lajin; A Alachkar; Sakur A Alhaj
Journal:  N Am J Med Sci       Date:  2012-05

5.  The Association of Low-Penetrance Variants in DNA Repair Genes with Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Nikhil Aggarwal; Neil D Donald; Salim Malik; Subothini S Selvendran; Mark Jw McPhail; Kevin J Monahan
Journal:  Clin Transl Gastroenterol       Date:  2017-07-27       Impact factor: 4.488

Review 6.  State of Art of Cancer Pharmacogenomics in Latin American Populations.

Authors:  Andrés López-Cortés; Santiago Guerrero; María Ana Redal; Angel Tito Alvarado; Luis Abel Quiñones
Journal:  Int J Mol Sci       Date:  2017-05-23       Impact factor: 5.923

7.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.